Effect of some antiparkinsonian drugs on catecholamine neurons.
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects; D001977:Brompheniramine / Q000494:pharmacology; D002744:Chlorpheniramine / Q000494:pharmacology; D003864:Depression, Chemical; D004298:Dopamine / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006651:Histocytochemistry; D066298:In Vitro Techniques; D007498:Iris / Q000378:metabolism; D008856:Microscopy, Fluorescence; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D014316:Tritium; D014326:Tropanes / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010880:Piperidines; D014326:Tropanes; D014316:Tritium; D002744:Chlorpheniramine; D001977:Brompheniramine; D004298:Dopamine; D009638:Norepinephrine